Cardiogenic shock

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Cardiogenic shock is defined as an inadequate cardiac output to maintain adequate perfusion of vital organs to meet ongoing demands for oxygenation. Cardiogenic shock is due to either inadequate left ventricular pump function (such as in congestive heart failure) or inadequate left ventricular filling (such as in cardiac tamponade or mitral stenosis with tachycardia). In so far as the course of treatment differs substantially, cardiogenic shock should be distinguished from other forms of shock such as septic shock and neurogenic shock.

Definition

Cardiogenic shock is defined by sustained hypotension with tissue hypoperfusion despite adequate left ventricular filling pressure. Signs of tissue hypoperfusion include oliguria (<30 mL/h), cool extremities, and altered mentation.

The pathophysiology of cardiogenic shock is complex and multifaceted, and as a result, diagnostic criteria for cardiogenic shock have been debated. Some clinicians argue that hypotension alone should not be the key criteria in so far as compensatory tachycardia and vasoconstriction may compensate for the reduced cardiac output to yield a mildly depressed systolic blood pressure. These clinicians advocate a hemodynamic definition with greater reliance placed on hemodynamic measures and interpretation of the cardiac output in the context of left ventricular filling pressure as often gauged by the pulmonary capillary wedge pressure. For instance, a patient who has a history of hypertension who now has a blood pressure of 100 mm Hg with a markedly elevated systemic vascular resistance (SVR) and pronounced tachycardia with a markedly reduced cardiac output, would be in cardiogenic shock in the judgement of some clinicians despite the absence of hypotension.

In clinical trials, cardiogenic shock has been defined as follows by the SHOCK investigators:

Clinical criteria

1. Systolic blood pressure <90 mm Hg
2. Evidence of hypoperfusion
3. Cool, clammy periphery
4. Decreased urine output
5. Decreased level of consciousness

Hemodynamic criteria

1. Left ventricular end diastolic pressure or pulmonary capillary wedge pressure >15 mm Hg
2. Cardiac index <2.2 L/min/m2

Pathophysiology of Cardiogenic Shock

Cardiogenic shock can be a complication of the follwoing conitions:

• Acute MI, more often ST elevation MI. Anterior MI with pronounced left ventricular dysfunction, posterior MI with acute mitral regurgitation, and inferior MI wiht right ventricular infarct physiology can be associated with cardiogenic shock.
• Tachyarrhythmias resulting in inadequate ventricular filling times and inadequate forward cardiac output.
• Congestive heart failure
• Cardiomyopathy
• Valvular heart disease including aortic stenosis, mitral stenosis with tachycardia and inadequate diastolic filling time.
• Aortic dissection
• Hypertrophic obstructive cardiomyopathy with systolic anterior motion (SAM)
• Ventricular septal defect
• Cardiac tamponade
• Iatrogenic due to excess administration of vasodilators and venodilators

Diagnosis

Symptoms

• Anxiety, restlessness, and an altered mental state may be present due to decreased cerebral perfusion and ensuing hypoxia.
• Fatigue may be present due to the work of breathing and hypoxia.

Physical Examination

Vitals

• Hypotension due to decrease in cardiac output.
• A rapid, weak, thready pulse due to decreased circulation combined with tachycardia.

Neck

• Distended jugular veins due to increased jugular venous pressure.

Skin

• Cool, clammy, and mottled skin (cutis marmorata), due to vasoconstriction and subsequent hypoperfusion of the skin.

Lungs

• Rapid and deep respirations (hyperventilation) due to sympathetic nervous system stimulation and acidosis.
• Oliguria (low urine output) due insufficient renal perfusion if condition persists.

• Absent pulse in tachyarrhythmia.
• Pulmonary Edema (fluid in the lungs) due to insufficient pumping of the heart, fluid backs up into the lungs.

Electrocardiogram

An Electrocardiogram helps establishing the exact diagnosis and guides treatment, it may reveal:

• Cardiac arrhythmias
• Signs of cardiomyopathy

Radiology

Echocardiography may show arrhythmia, signs of PED, ventricular septal rupture (VSR), an obstructed outflow tract or cardiomyopathy.

Swan-ganz catheter

The Swan-ganz catheter or Pulmonary artery catheter may assist in the diagnosis by providing information on the hemodynamics.

Biopsy

In case of suspected cardiomyopathy a biopsy of heart muscle may be needed to make a definite diagnosis.

Treatment

In cardiogenic shock: depending on the type of myocardal infarction one can infuse fluids or in shock refractory to infusing fluids, inotropes should be administered. Positive inotropic agents, which enhance the heart's pumping capabilities, are used to improve the contractility and correct the hypotension. Should that not suffice an intra-aortic balloon pump (which reduces workload for the heart, and improves perfusion of the coronary arteries) can be considered or a left ventricular assist device (which augments the pump-function of the heart).

See also

• Intra-aortic balloon pump
• Ventricular assist device

Sources

• Irwin, R.S., Rippe, J.M., Curley, F.J., Heard, S.O. (1997) Procedures and Techniques in Intensive Care Medicine (3rd edition). Boston: Lippincott, Williams and Wilkins.
• Marino, P. (1997) The ICU Book. (2nd edition). Philadelphia: Lippincott, Williams and Wilkins.

External links

• Cardiogenic Shock by eMedicine